Bristol-Myers Squibb Earnings Top Estimates

Bristol-Myers Squibb (BMY), which sells blood thinner Plavix, today reported better-than-expected third quarter earnings, mainly due to cost cuts. Revenue, however, fell short of expectations.

Bristol - Myers buyout of Medarex

Shares in Human Genome Sciences (HGSI) rocketed up on news that it had received promising results for its lupus drug. Suddenly, the successes -- and...